Quince Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Quince Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- QNCX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001662774
Board of directors
-
Brigette Roberts · Director · Chief Corp. Affairs OfficerSince 2026
-
Christopher J. Senner · DirectorSince 2023
-
David Lamond · DirectorSince 2023
-
Dirk Thye · Director · CEO and CMOSince 2023
-
June Bray · DirectorSince 2023
-
Luca Benatti · DirectorSince 2023
-
Margaret McLoughlin · DirectorSince 2023
-
Rajiv Patni · DirectorSince 2024
-
Una S. Ryan · DirectorSince 2023
Chief executives
Dirk Thye
· Chief Executive Officer
Dates unknown
Board connections
1 of this board's directors also sit on 1 other board.
- via Una S. Ryan
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $173,500
- 1 sale by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 26, 2025 | Luca Benatti Director | Open-market sale | −50,000 | $3.47 | $173,500 |
| Dec 10, 2025 | Dirk Thye Director, Officer (CEO and CMO) | Gift | −739,885 | — | — |
| Dec 10, 2025 | Dirk Thye Director, Officer (CEO and CMO) | Gift | +739,885 | — | — |
| Dec 5, 2025 | Hannah Brendan Officer (CBO, COO & CCO) | Option exercise | +2,271 | $0.55 | $1,249 |
| Dec 5, 2025 | Hannah Brendan Officer (CBO, COO & CCO) | Option exercise | +25,280 | $0.94 | $23,763 |
| Jun 18, 2025 | Hannah Brendan Officer (CBO, COO & CCO) | Grant or award | +37,736 | $1.20 | $45,283 |
| Jun 18, 2025 | Ryan Charles S. Officer (President) | Grant or award | +7,548 | $1.20 | $9,058 |
| Jun 18, 2025 | Dirk Thye Director, Officer (CEO and CMO) | Grant or award | +150,944 | $1.20 | $181,133 |
| Oct 23, 2024 | Luca Benatti Director | Other | +8,918 | — | — |
| Aug 30, 2024 | Dirk Thye Director, Officer (CEO AND CHIEF MEDICAL OFFICER) | Open-market purchase | +77,000 | $0.70 | $53,900 |
| Aug 29, 2024 | Dirk Thye Director, Officer (CEO AND CHIEF MEDICAL OFFICER) | Open-market purchase | +77,500 | $0.69 | $53,475 |
| Aug 21, 2024 | Hannah Brendan Officer (CHIEF BUSINESS OFFICER AND COO) | Open-market purchase | +2,280 | $0.61 | $1,391 |
| Aug 21, 2024 | Hannah Brendan Officer (CHIEF BUSINESS OFFICER AND COO) | Open-market purchase | +5,000 | $0.62 | $3,100 |
| Aug 21, 2024 | Hannah Brendan Officer (CHIEF BUSINESS OFFICER AND COO) | Open-market purchase | +23,565 | $0.63 | $14,846 |
| Aug 20, 2024 | Ryan Charles S. Officer (PRESIDENT) | Open-market purchase | +48,387 | $0.65 | $31,452 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.